The Effects of Raspberry Leaf Tea on Blood Glucose Control
NCT ID: NCT06385626
Last Updated: 2024-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2023-12-18
2024-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The questions the project will address:
* Do raspberry leaf polyphenols lower sucrose-induced increases in plasma glucose in humans?
* Do these polyphenols mediate these effects by inhibiting digestion of sucrose or the absorption of glucose.
20 healthy adults will be recruited between the ages of 18-65 years who are non-smokers and not taking certain types of medication (e.g., drugs from a GP for high blood pressure, high blood fats, inflammatory conditions, and depression) or dietary supplements (e.g., cholesterol-lowering spreads, fish oil, probiotics, prebiotics, and natural laxatives), antibiotics in the last three months or if they used any drugs or supplements that could affect their blood glucose or lipid metabolism. No abnormal results for liver function tests, renal function tests, and lipid profile tests. If they have food allergies or consume more than 14 units of alcohol per week (i.e., to help they calculate a alcohol intake, one standard glass of wine (175 ml) or one pint of regular lager is equivalent to just over two units of alcohol), frequently travel for work or are participating in another intervention study, they will not be able to participate. Women who are pregnant or lactating or planning a pregnancy in the next six months will also not be able to take part, not use herbal medicines for at least the previous three months, not be on a weight loss program six months before screening, not involved in clinical trials six months before the screening, and not having severe cardiac, hepatic, or renal function impairment. Not Sufferers of chronic illnesses, not Individuals with food allergies, not people with coeliac disease.
They will be asked to attend a four-study visit after an eight-hour overnight fast. Volunteers will be asked to consume 50 g of carbohydrate powder (sucrose and glucose) with or without 10 g of raspberry leaf tea, which will be dissolved in 300 mL of warm water during four visits (every month). Blood samples will be taken at intervals for a period of two hours after the consumption of raspberry leaf or control. Blood glucose and insulin levels will be tested 15 minutes before, at 15,30,60,90, and 120 minutes after carbohydrate intake.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Red Raspberries on Insulin Action and Oxidative Stress
NCT02479035
Strawberries and Risk of Diabetes in Adults
NCT05362968
Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption
NCT00262145
Mulberry Leaf Extract and Blood Glucose Control in Diabetics
NCT01305434
The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults
NCT03921333
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The volunteer exclusion criteria are: (Smoking, Pregnancy/lactation; Use of herbal medicines for at least the previous three months; Involved in a weight loss program six months before screening; Involved in clinical trial six months before the screening; Had severe cardiac, hepatic, or renal function impairment; Sufferers of chronic illnesses; Individuals with food allergies; People with prediabetes or diabetes; People with coeliac disease)
If all subjects are generally healthy, as demonstrated by their medical history and laboratory tests, including fasting blood sugar and insulin levels, as well as HOMA-IR, liver function tests (alanine transaminase, alkaline phosphatase, total bilirubin, and gamma-GT), renal function tests (uric acid and creatinine), and lipid profile tests (total cholesterol, Triglycerides). They will be asked to attend a four-study visit after an eight-hour overnight fast. Volunteers will be asked to consume 50 g of carbohydrate powder (sucrose and glucose) with or without 10 g of raspberry leaf tea, which will be dissolved in 300 mL of warm water during four visits (every month). Blood samples will be taken at intervals for a period of two hours after the consumption of raspberry leaf or control. Blood glucose and insulin levels will be tested 15 minutes before, at 15,30,60,90, and 120 minutes after carbohydrate intake.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sucrose + raspberry leaf tea
Volunteers will be asked to consume 50 g of sucrose with 10 g of raspberry leaf tea dissolved in 300 mL of warm water.
Raspberry leaf tea
10 g of raspberry leaf tea
glucose + raspberry leaf tea
Volunteers will be asked to consume 50 g of glucose with10 g of raspberry leaf tea dissolved in 300 mL of warm water.
Raspberry leaf tea
10 g of raspberry leaf tea
sucrose
Volunteers will be asked to consume 50 g of sucrose without 10 g of raspberry leaf tea
Raspberry leaf tea
10 g of raspberry leaf tea
glucose
Volunteers will be asked to consume 50 g of glucose without 10 g of raspberry leaf tea
Raspberry leaf tea
10 g of raspberry leaf tea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Raspberry leaf tea
10 g of raspberry leaf tea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A signed consent forms.
* Age 18-65 years
* Body mass index ≤ 34.9 kg/m2
* Non-smoking
* No pregnancy/lactation
* No use of herbal medicines for at least the previous three months
* Not on a weight loss program six months before screening
* Not involved in clinical trial six months before screening
* Not had severe cardiac, hepatic, or renal function impairment
Exclusion Criteria
* Pregnancy/lactation
* Use of herbal medicines for at least the previous three months
* Involved in a weight loss program six months before screening.
* Involved in clinical trial six months before the screening.
* Had severe cardiac, hepatic, or renal function impairment.
* Sufferers of chronic illnesses
* Individuals with food allergies
* People with prediabetes or diabetes
* People with coeliac disease
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Reading
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeremy Paul Edward Spencer
Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeremy Spencer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hugh Sinclair Unit of Human Nutrition, University of Reading
Reading, Berkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UREC: 23_15-Raspberry Leaf Tea
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.